--
--(--)
--
--(--)
Expected P&L on Expiry
Key Stats
0.00DAY`S RANGE0.00
0.00
0.00
--
--
--
--
--
--
--
Pricing Model
--
--
--
--
--
--
About RXRX20260918C4
Medical service
Recursion Pharmaceuticals, Inc., was originally established on November 4, 2013 and is incorporated in Delaware. The company is a leading clinical-stage TechBio company that decodes biology to industrialize drug discovery. At the heart of the company's mission is the Recursive Operating System (OS), a platform built across multiple technologies that enables the company to map and navigate trillions of biological, chemical and patient-centric relationships in over 50 petabytes of proprietary data. The company frames this integration of physical and digital components as an iterative loop in which large-scale "wet lab" biological, chemical and patient-centric experimental data are organized by "dry lab" computing tools in order to identify, validate and translate therapeutic insights.
